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Introduction
The hepatitis C virus (HCV) is a positive single-stranded RNA virus transmitted by blood-to-blood contact. Its gene contains approximately 9400 nucleotides. Persistent HCV infection is common among most HCV-infected patients and chronic hepatitis results in cirrhosis of the liver and hepatocellular carcinomas. The standard HCV typing approach uses core/E1, NS5B or other genetic sequences. HCV is one of several viral genes that are limited to specific geographic regions and/or ethnic groups, thus supporting their use in epidemiological research. 1 Efforts to type the HCV gene have resulted in the identification of six primary types and multiple subtypes. 2 HCV genotype 1a or 1b patients are prone to more severe cases of liver disease and lower response rates to interferon therapy compared to genotype 2a or 2b patients. 3 Accordingly, HCV genotype testing is required to determine the duration of interferon-based 8, 9 In the past we have used multiplex real-time (RT)-PCR methods with HCV core genes for epidemiological studies involving Taiwanese injecting drug users (IUDs). 10 We found that primers designed for HCV subtype 4 occasionally react with some subtype 6a viral sequences, resulting in incorrect identification problems. Furthermore, we discovered a new 6n subtype, and determined that the 6w subtype is rare in Taiwan. Our motivation for the present study was to develop a more accurate multiplex RT-PCR method for identifying 6a, 6n and 6w subtypes. We used serum samples from a group of Taiwanese IDUs for evaluation purposes, and used Inno-LiPa tests and sequence analyses to evaluate the accuracy of our results. Our ultimate goal was to create a simple genotyping method for clinical applications and epidemiological research.
Materials and methods

Participants and serologic assays
In 2008, we collected serum specimens from 48 HIV-1-positive and 28 HIV-1-negative IDUs at the Sindian Drug User Treatment Center in northern Taiwan. Specimens were stored at À80 C until used. Each participant signed a consent form. All specimens were tested using thirdgeneration immunological enzyme HCV antibodies according to the manufacturer's instructions (Abbott Laboratories, Chicago, USA).
Modified multiplex RT-PCR protocol
Our proposed genotyping system is a modification of the protocol given in an article by Ohno et al, 11 with two new primers designed for the HCV 6n and 6w subtypes. We observed that an antisense primer 4 reacted with HCV subtype 6a isolates, and therefore labeled it as HCV type 4-specific antisense primer 4r. All anti-HCV-positive samples were tested using multiplex RT-PCR methods. Viral RNA was extracted from 140 ml aliquots of serum using QIAamp RNA extraction kits (Qiagen, Hilden, Germany). HCVcomplementary DNA was synthesized and amplified using random primers (Promega, Canada). The first round RT-PCR primer pairs were Sc2 and LF. Second round PCR was performed in three separate reaction tubes with different primer groups (see Table 1 ). This procedure can be used to test for HCV subtypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, 6a, 6n and 6w. Typical electrophoresis patterns for PCR products among various HCV genotypes were showed in Fig. 1 .
Inno-LiPa II tests
To evaluate multiplex RT-PCR analysis sensitivity and specificity, 20 serum specimens were selected (including subtypes 1a, 1b, 2a, 2b, 3a, 3b, 6a, 6n and 6w) for secondgeneration Inno-LiPa II tests (Innogenetics, Ghent, Belgium) and sequence analysis. The specimens were from 18 IDUs with single hepatitis C infections and two with multiple infections. Tests were performed according to the manufacturer's instructions.
Core and NS5B HCV sequencing
Core region phylogenetic analyses were performed using methods described by Ohno et al. 11 For NS5B analyses, Figure 1 Typical electrophoresis patterns for PCR products among various HCV genotypes, as determined by our proposed typing system. HCV genotype-specific product sizes in mixes 1, 2 and 3. RT-PCR products were used for additional nested PCR amplification with TaKaRa Ex TaqTM (TaKaRa Bio Inc., Otsu, Japan). The first round PCR primer pair was forward primer NS5B-F1 (5 0 -AACCACATCCACTCCGTGTGG-3 0 ) and reverse primer NS5B-R1 (5 0 -GGTCTTTACCGCCCAGTTGAA GAG-3 0 ). The second round pair was forward primer NS5B-F1 and reverse primer BS5B-SR2 (5 0 -TACCTGGTCA TAGCCTCCGTGAAG-3 0 ). As part of the PCR reaction, 2 ml of complementary DNA was amplified for 40 cycles as follows: 20 cycles of denaturing at 94 C for 1 minute, annealing at 45 C for 1 minute, and extension at 72 C for 1 minute, followed by 20 cycles at 94 C for 1 minute, 60 C for 1 minute, and 72 C for 1 minute. For the second PCR round, 0.5 ml of first-round PCR product was amplified for 30 cycles of denaturing at 94 C for 1 minute, followed by annealing at 62 C for 45 seconds, and extension at 72 C for 1 minute.
Phylogenetic analysis
HCV genotype/subtype sequence alignments were determined using BioEdit 3.7 (Abbott, Carlsbad, CA, USA), with sequences from the Los Alamos database used as a reference group (www.ncbi.nlm.nih.gov/). Neighbor-joining phylogenetic trees were constructed using Kimura's two-parameter distance matrix (1000 bootstrap replications). MEGA 3.1 (MEGA, Tempe, AZ, USA) and PHYLIP 3.6 (University of Washington, USA) were used to construct neighbor-joining trees and to verify taxa topologies in maximum-likelihood trees, respectively.
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The sequence for HCV strain H77 (accession number AF009606) was used as a reference. We used the 8000-8604 (605 nt) segment from the NS5B region for phylogenetic analysis (Fig. 1) .
Results
Multiplex RT-PCR genotyping
The positive anti-HCV antibody rate was significantly higher in HIV-1-positive IDUs than in HIV-1-negative IDUs (100% vs. 78.6%, p Z 0.002). According to our multiplex RT-PCR results, exactly two-thirds (32/48) of the HIV-1-positive IDUs were infected with a single hepatitis C virus typedprimarily the 6a genotype (12/48, 25%), followed by 1a and 1b (6/48 or 12.5% each). Two participants (4.2%) were identified as having double HCV infections. Among the HIV-1-negative IDUs, exactly one-half (14/28) were infected with a single HCV typedprimarily 6a, followed by 1a (4/28, 14.3%); only one participant (3.6%) was identified as having a double infection. No statistically significant differences were noted for any distributions between the two groups. Two HIV-1-negative IDUs were infected with the 6w subtype. No HCV signals were found in 29.2% of the HIV-1-positive and 25% of the HIV-1-negative IDUs (see Table 2 ).
Determining HCV genotype by sequence analysis
According to results from more than 50% of our NS5B gene sequence analyses specimens, the use of auxiliary determinations from subtype 4r primers increased the accuracy of 6a strain identification. Furthermore, the phylogenetic trees produced by our proposed multiplex RT-PCR and NS5B gene sequencing methods were 100% identical. Subtype 6n and 6w strains identified by multiplex RT-PCR genotyping assays were confirmed by sequence analysis (see Fig. 2 ). Table 2 Distribution of HCV genotypes in the injecting drug users group. 
Inno-LiPa II tests
Results from line probe hybridization assays based on NS5B gene sequencing indicate 85% (17/20) correct genotype determinations for the sequence analysis. Discrepancies included one case of 6n misdiagnosed as 1b, two cases of 6w misdiagnosed as 1b, and five cases of 6a infections that were actually combinations of 6a and genotype 2 (see supplemental Fig. 1 ).
Discussion
Our results indicate identical levels of sensitivity and specificity between our proposed method and both gene sequencing and phylogenetic tree analyses for detecting single subtype reactions. Our proposed method was superior in terms of detecting double HCV subtype infections.
To evaluate their multiplex RT-PCR method, Ohno et al used 607 samples collected in Japan, the US, Korea, Taiwan, China, Hong Kong, Australia, Egypt, Bangladesh and South Africa. Their results from 539 samples (88.8%) were concordant with those from a multiplex RT-PCR system reported by Okamoto et al. 9 Moreover, the genotypes of the 23 (out of 68) samples with discordant results had been determined by sequence analysis, which concurred with Ohno et al's genotyping systems. Zhou et al, however, reported that some 1b subtypes were wrongly identified as 6a and some 6a subtypes identified as 1b using Ohno et al's method. 14 HCV subtypes 6a-w are mostly found in IDUs living along major drug trafficking routes in Vietnam, Thailand, Hong Kong and China; most likely the IDUs transmit the virus via shared syringes. Between 2003 and 2005, Taiwan experienced a surge in infection rates for subtypes 6a (23.5%), 3a (20.2%) and 1a (29.2%). 15 During that period, researchers identified two new subtypes: 6n and 6w. A 13.3% increase in individuals with multiple infections has also been reported. 10 Proper diagnosis of HCV subtypes in Southeast Asia requires increased primer specificity. We offer our method as a step toward achieving that goal.
In this study, we used data from a 2008 project involving Taiwanese IDUs. Our proposed multiplex RT-PCR procedure successfully identified two cases of the 6w subtype; Figure 2 Phylogenetic trees based on: (A) partial core region sequences corresponding to nt 338e581, using maximum-likelihood methods; and (B) partial NS5B region sequences corresponding to nt 8000e8578 in neighbor-joining trees. The H77 genome (Genbank accession number NC004102) was used as a reference. Key: C Z the strains found in this study; : Z 6 w strain * Z indicated confidence limits of p < 0.01. a clustering effect noted in our phylogenetic tree analysis verified this 6w result. This subtype was found in the HIV-1-negative IDU group. To validate the accuracy and reliability of this modified genotyping protocol, we applied the new protocol to test samples selected from the previous study. 10 The results showed that all the 6n (five cases) and 6w (three cases) subtypes could be determined correctly and the 28 misclassified subtype 4 cases could be correctly reclassified to subtype 6a.
In our previous study, the serum samples collected from 2004 to 2005 showed that subtypes 1b (36.0%) and 6a (30.0%) were the most common ones found in northern Taiwan. In this study, we selected samples from 2008 from when genotype 6a was the most common subtype. The difference in subtypes seen between 2004 and 2008 may be caused by the differences in samples time and needle-sharing behaviors observed in the IDUs. We therefore suggest that future researchers focus on the 6w strain when considering issues associated with hepatitis C diagnosis and treatment.
